ADVC-001

N/A

Report date: 2025/11/26 17:11:23
NME

Base Information

Drug NameADVC-001
Drug Alias NameADVC-001212 Pb ADVC 001212-lead ADVC 001212Pd ADVC001212Pb-ADVC001 +[6] 
ClassificationRadiation-emitting products > Nuclides > Lead > 212PbRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive therapeutic agent +[4] 
Mechanisms of ActionIonising radiation emittersProstate-Specific Membrane Antigen binders
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAdvancell Advanced In Vitro Cell Technologies Sa
China Registration ClassN/A

Develop Information

Active CompaniesAdvanCell Pty LtdAdvancell Advanced In Vitro Cell Technologies Sa
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A